5-HT6 receptor agonism facilitates emotional learning

Frontiers in Pharmacology

Volumn 6, Issue SEP, 2015, Pages

  Pereira, Marcela ^a   Martynhak, Bruno J ^a   Andreatini, Roberto ^b   Svenningsson, Per ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

5 HT6; Antidepressant; C fos; Forced swim test; MAPK; Memory; Passive avoidance

Indexed keywords

3 [(3 FLUOROPHENYL)SULFONYL] N,N DIMETHYL 1H PYRROLO[2,3 B]PYRIDINE 1 ETHANAMINE; BRAIN DERIVED NEUROTROPHIC FACTOR; GLUTAMATE RECEPTOR 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NEUROTROPHIC FACTOR; PHOSPHOSERINE; PHOSPHOTHREONINE; PRO BRAIN DERIVED NEUROTROPHIC FACTOR; PROTEIN PRECURSOR; SEROTONIN 6 RECEPTOR; SEROTONIN AGONIST; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ANXIETY; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ELEVATED PLUS MAZE TEST; EMOTIONAL LEARNING; FORCED SWIM TEST; GENE EXPRESSION; GROOMING; HIPPOCAMPUS; IMMEDIATE EARLY GENE; LEARNING; LOCOMOTION; LONG TERM MEMORY; MALE; MOOD; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; OPEN FIELD TEST; PASSIVE AVOIDANCE TEST; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PUTAMEN; REARING; SHORT TERM MEMORY; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE;

EID: 84944732770     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00200     Document Type: Article

References (41)

1. Baamonde, A., Dauge, V., Ruizgayo, M., Fulga, I. G., Turcaud, S., Fourniezaluski, M. C., et al. (1992). Antidepressant-type effects of endogenous enkephalins protected by systemic rb-101 are mediated by opioid-delta and dopamine-d1 receptor stimulation. Eur. J. Pharmacol. 216, 157-166. doi: 10.1016/0014-2999(92)90356-9
2. Burnham, K. E., Baxter, M. G., Bainton, J. R., Southam, E., Dawson, L. A., Bannerman, D. M., et al. (2010). Activation of 5-HT(6) receptors facilitates attentional set shifting. Psychopharmacology (Berl.) 208, 13-21. doi: 10.1007/s00213-009-1701-6
3. Burwell, R. D., Saddoris, M. P., Bucci, D. J., and Wiig, K. A. (2004). Corticohippocampal contributions to spatial and contextual learning. J. Neurosci. 24, 3826-3836. doi: 10.1523/JNEUROSCI.0410-04.2004
4. Carr, G. V., Schechter, L. E., and Lucki, I. (2011). Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats. Psychopharmacology (Berl.) 213, 499-507. doi: 10.1007/s00213-010-1798-7
5. Cervo, L., Mennini, T., Rozio, M., Ekalle-Soppo, C. B., Canetta, A., Burbassi, S., et al. (2005). Potential antidepressant properties of IDN 5491 (hyperforin-trimethoxybenzoate), a semisynthetic ester of hyperforin. Eur. Neuropsychopharmacol. 15, 211-218. doi: 10.1016/j.euroneuro.2004.07.004
6. Clayton, D. F. (2000). The genomic action potential. Neurobiol. Learn. Mem. 74, 185-216. doi: 10.1006/nlme.2000.3967
7. de Foubert, G., O'Neill, M. J., and Zetterström, T. S. C. (2007). Acute onset by 5-HT(6)-receptor activation on rat brain brain-derived neurotrophic factor and activity-regulated cytoskeletal-associated protein mRNA expression. Neuroscience 147, 778-785. doi: 10.1016/j.neuroscience.2007.04.045
8. Eriksson, T. M., Alvarsson, A., Stan, T. L., Zhang, X., Hascup, K. N., Hascup, E. R., et al. (2013). Bidirectional regulation of emotional memory by 5-HT1B receptors involves hippocampal p11. Mol. Psychiatry 18, 1096-1105. doi: 10.1038/mp.2012.130
9. Eriksson, T. M., Madjid, N., Elvander-Tottie, E., Stiedl, O., Svenningsson, P., and Ogren, S. O. (2008). Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission. Neuropharmacology 54, 1041-1050. doi: 10.1016/j.neuropharm.2008.02.007
10. Ferretti, V., Perri, V., Cristofoli, A., Vetere, G., Fragapane, P., Oliverio, A., et al. (2014). Phosphorylation of S845 GluA1 AMPA receptors modulates spatial memory and structural plasticity in the ventral striatum. Brain Struct. Funct. 220, 2653-2661. doi: 10.1007/s00429-014-0816-7
11. Guzzetti, S., Calcagno, E., Canetta, A., Sacchetti, G., Fracasso, C., Caccia, S., et al. (2008). Strain differences in paroxetine-induced reduction of immobility time in the forced swimming test in mice: role of serotonin. Eur. J. Pharmacol. 594, 117-124. doi: 10.1016/j.ejphar.2008.07.031
12. Hirano, K., Piers, T. M., Searle, K. L., Miller, N. D., Rutter, A. R., and Chapman, P. F. (2009). Procognitive 5-HT6 antagonists in the rat forced swimming test: potential therapeutic utility in mood disorders associated with Alzheimer's disease. Life Sci. 84, 558-562. doi: 10.1016/j.lfs.2009.01.019
13. Hirst, W. D., Abrahamsen, B., Blaney, F. E., Calver, A. R., Aloj, L., Price, G. W., et al. (2003). Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling. Mol. Pharmacol. 64, 1295-1308. doi: 10.1124/mol.64.6.1295
14. Hirst, W. D., Stean, T. O., Rogers, D. C., Sunter, D., Pugh, P., Moss, S. F., et al. (2006). SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models. Eur. J. Pharmacol. 553, 109-119. doi: 10.1016/j.ejphar.2006.09.049
15. Katche, C., Bekinschtein, P., Slipczuk, L., Goldin, A., Izquierdo, I. A., Cammarota, M., et al. (2010). Delayed wave of c-Fos expression in the dorsal hippocampus involved specifically in persistence of long-term memory storage. Proc. Natl. Acad. Sci. U.S.A. 107, 349-354. doi: 10.1073/pnas.0912931107
16. Kendall, I., Slotten, H. A., Codony, X., Burgueño, J., Pauwels, P. J., Vela, J. M., et al. (2011). E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat. Psychopharmacology (Berl.) 213, 413-430. doi: 10.1007/s00213-010-1854-3
17. Kindlundh-Högberg, A. M. S., Zhang, X., and Svenningsson, P. (2009). S100B overexpressing mutant mice exhibit prolonged behavioural and biochemical responses towards repeated intermittent binge treatments with MDMA. Int. J. Neuropsychopharmacol. 12, 201-215. doi: 10.1017/S1461145708009437
18. Lieben, C. K. J., Blokland, A., Sik, A., Sung, E., van Nieuwenhuizen, P., and Schreiber, R. (2005). The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat. Neuropsychopharmacology 30, 2169-2179. doi: 10.1038/sj.npp.1300777
19. Liu, M. Y., Wang, S., Yao, W. F., Zhang, Z. J., Zhong, X., Sha, L., et al. (2014). Memantine improves spatial learning and memory impairments by regulating NGF signaling in APP/PS1 transgenic mice. Neuroscience 273, 141-151. doi: 10.1016/j.neuroscience.2014.05.011
20. McReynolds, J. R., Donowho, K., Abdi, A., McGaugh, J. L., Roozendaal, B., and McIntyre, C. K. (2010). Memory-enhancing corticosterone treatment increases amygdala norepinephrine and Arc protein expression in hippocampal synaptic fractions. Neurobiol. Learn. Mem. 93, 312-321. doi: 10.1016/j.nlm.2009.11.005
21. Meneses, A., Manuel-Apolinar, L., Castillo, C., and Castillo, E. (2007). Memory consolidation and amnesia modify 5-HT6 receptors expression in rat brain: an autoradiographic study. Behav. Brain Res. 178, 53-61. doi: 10.1016/j.bbr.2006.11.048
22. Misane, I., and Ogren, S. O. (2000). Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT. Neuropsychopharmacology 22, 168-190. doi: 10.1016/S0893-133X(99)00109-8
23. Mitchell, E. S., and Neumaier, J. F. (2005). 5-HT6 receptors: a novel target for cognitive enhancement. Pharmacol. Ther. 108, 320-333. doi: 10.1016/j.pharmthera.2005.05.001
24. Mitchell, E. S., Sexton, T., and Neumaier, J. F. (2007). Increased expression of 5-HT6 receptors in the rat dorsomedial striatum impairs instrumental learning. Neuropsychopharmacology 32, 1520-1530. doi: 10.1038/sj.npp.1301284
25. Ogren, S. O., Eriksson, T. M., Elvander-Tottie, E., D'Addario, C., Ekström, J. C., Svenningsson, P., et al. (2008). The role of 5-HT(1A) receptors in learning and memory. Behav. Brain Res. 195, 54-77. doi: 10.1016/j.bbr.2008.02.023
26. Ongür, D., and Price, J. L. (2000). The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb. Cortex 10, 206-219. doi: 10.1093/cercor/10.3.206
27. Pei, Q., Tordera, R., Sprakes, M., and Sharp, T. (2004). Glutamate receptor activation is involved in 5-HT2 agonist-induced Arc gene expression in the rat cortex. Neuropharmacology 46, 331-339. doi: 10.1016/j.neuropharm.2003.09.017
28. Prado-Alcalá, R. A., Fernández-Samblancat, M., and Solodkin-Herrera, M. (1985). Injections of atropine into the caudate nucleus impair the acquisition and the maintenance of passive avoidance. Pharmacol. Biochem. Behav. 22, 243-247. doi: 10.1016/0091-3057(85)90385-5
29. Prut, L., and Belzung, C. (2003). The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur. J. Pharmacol. 463, 3-33. doi: 10.1016/S0014-2999(03)01272-X
30. Riccioni, T., Bordi, F., Minetti, P., Spadoni, G., Yun, H.-M., Im, B.-H., et al. (2011). ST1936 stimulates cAMP, Ca2+, ERK1/2 and Fyn kinase through a full activation of cloned human 5-HT6 receptors. Eur. J. Pharmacol. 661, 8-14. doi: 10.1016/j.ejphar.2011.04.028
31. Schechter, L. E., Lin, Q., Smith, D. L., Zhang, G., Shan, Q., Platt, B., et al. (2008). Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacology 33, 1323-1335. doi: 10.1038/sj.npp.1301503
32. Svenningsson, P., Chergui, K., Rachleff, I., Flajolet, M., Zhang, X., El Yacoubi, M., et al. (2006). Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 311, 77-80. doi: 10.1126/science.1117571
33. Svenningsson, P., Nergårdh, R., and Fredholm, B. B. (1998). Regional differences in the ability of caffeine to affect haloperidol-induced striatal c-fos mRNA expression in the rat. Neuropharmacology 37, 331-337. doi: 10.1016/S0028-3908(98)00045-8
34. Svenningsson, P., Tzavara, E. T., Qi, H., Carruthers, R., Witkin, J. M., Nomikos, G. G., et al. (2007). Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation. J. Neurosci. 27, 4201-4209. doi: 10.1523/JNEUROSCI.3110-06.2007
35. Thomas, G. M., and Huganir, R. L. (2004). MAPK cascade signalling and synaptic plasticity. Nat. Rev. Neurosci. 5, 173-183. doi: 10.1038/nrn1346
36. Wesolowska, A., and Nikiforuk, A. (2007). Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. Neuropharmacology 52, 1274-1283. doi: 10.1016/j.neuropharm.2007.01.007
37. Wesolowska, A., and Nikiforuk, A. (2008). The selective 5-HT6 receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats. Eur. J. Pharmacol. 582, 88-93. doi: 10.1016/j.ejphar.2007.12.013
38. Wilkinson, D., Windfeld, K., and Colding-Jørgensen, E. (2014). Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet. Neurol. 13, 1092-1099. doi: 10.1016/S1474-4422(14)70198-X
39. Woods, S., Clarke, N. N., Layfield, R., and Fone, K. C. F. (2012). 5-HT(6) receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms. Br. J. Pharmacol. 167, 436-449. doi: 10.1111/j.1476-5381.2012.02022.x
40. Yun, H.-M., Kim, S., Kim, H.-J., Kostenis, E., Kim, J. I., Seong, J. Y., et al. (2007). The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn. J. Biol. Chem. 282, 5496-5505. doi: 10.1074/jbc.M606215200
41. Zhang, X., Andren, P. E., Glennon, R. A., and Svenningsson, P. (2011). Distribution, level, pharmacology, regulation, and signaling of 5-HT6 receptors in rats and marmosets with special reference to an experimental model of parkinsonism. J. Comp. Neurol. 519, 1816-1827. doi: 10.1002/cne.22605